Akadeum Life Sciences Overview
- Year Founded
-
2014

- Status
-
Private
- Employees
-
24

- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$20M
- Investors
-
35
Akadeum Life Sciences General Information
Description
Developer of bio-separation products designed to facilitate the removal of target cells from biological samples. The company's products are based on buoyancy-activated cell sorting that uses microscopic micro-bubbles to capture target cells and quickly float them to the surface of a liquid sample for removal, enabling medical practitioners to use those cells for performing downstream testing and analysis with increased efficiency.
Contact Information
Website
www.akadeum.comCorporate Office
- 674 South Wagner Road
- Ann Arbor, MI 48103
- United States
Corporate Office
- 674 South Wagner Road
- Ann Arbor, MI 48103
- United States
Akadeum Life Sciences Timeline
Akadeum Life Sciences Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
13. Later Stage VC | 03-Jun-2025 | $20M | Completed | Generating Revenue | ||
12. Accelerator/Incubator | 23-May-2023 | Completed | Generating Revenue | |||
11. Later Stage VC | 16-May-2023 | Completed | Generating Revenue | |||
10. Secondary Transaction - Private | 22-Feb-2022 | Completed | Generating Revenue | |||
9. Later Stage VC (Series B) | 29-Sep-2021 | Completed | Generating Revenue | |||
8. Later Stage VC (Series A) | 11-May-2020 | Completed | Generating Revenue | |||
7. Later Stage VC (Series A1) | 01-Feb-2019 | Completed | Generating Revenue | |||
6. Seed Round | 28-Sep-2017 | Completed | Startup | |||
5. Seed Round | 31-Jul-2015 | $1M | $1.15M | Completed | Startup | |
4. Seed Round | 21-Oct-2014 | $150K | $150K | Completed | Startup |
Akadeum Life Sciences Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | ||||||||
Series B-2 | ||||||||
Series B-1 | ||||||||
Series A-1 | ||||||||
Series A | ||||||||
Seed Prime | 5,492,508 | $0.001000 | $0.03 | $0.33 | $0.33 | 1x | $0.33 | 2.59% |
Seed | 3,627,200 | $0.001000 | $0.02 | $0.29 | $0.29 | 1x | $0.29 | 1.71% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Akadeum Life Sciences Comparisons
Industry
Financing
Details
Akadeum Life Sciences Competitors (21)
One of Akadeum Life Sciences’s 21 competitors is LevitasBio, a Venture Capital-Backed company based in Menlo Park, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
LevitasBio | Venture Capital-Backed | Menlo Park, CA | ||||
Cytena | Formerly VC-backed | Freiburg, Germany | ||||
FiberCell Systems | Formerly Accelerator/Incubator backed | New Market, MD | ||||
Macopharma | Corporation | Tourcoing, France | ||||
StemCell Technologies | Private Debt Financed | Vancouver, Canada |
Akadeum Life Sciences Patents
Akadeum Life Sciences Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20240272139-A1 | Method and system for partially or fully automated buoyancy-assisted separation | Active | 14-Feb-2023 | ||
US-12099050-B2 | Method and system for partially or fully automated buoyancy-assisted separation | Active | 14-Feb-2023 | ||
US-20240402150-A1 | Method and system for partially or fully automated buoyancy-assisted separation | Pending | 14-Feb-2023 | ||
US-20230314428-A1 | Method and system for buoyant-particle-assisted cell therapy | Active | 01-Apr-2022 | ||
US-12196754-B2 | Method and system for buoyant-particle-assisted cell therapy | Active | 01-Apr-2022 | G01N33/56972 |
Akadeum Life Sciences Signals
Akadeum Life Sciences Investors (35)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
NYBC Ventures | Corporate Venture Capital | Minority | ||
Innovation Partnerships | Venture Capital | Minority | ||
Michigan Biomedical Venture Fund | Venture Capital | Minority | ||
Arboretum Ventures | Venture Capital | Minority | ||
ArgoPond | Venture Capital | Minority |
Akadeum Life Sciences FAQs
-
When was Akadeum Life Sciences founded?
Akadeum Life Sciences was founded in 2014.
-
Where is Akadeum Life Sciences headquartered?
Akadeum Life Sciences is headquartered in Ann Arbor, MI.
-
What is the size of Akadeum Life Sciences?
Akadeum Life Sciences has 24 total employees.
-
What industry is Akadeum Life Sciences in?
Akadeum Life Sciences’s primary industry is Biotechnology.
-
Is Akadeum Life Sciences a private or public company?
Akadeum Life Sciences is a Private company.
-
What is Akadeum Life Sciences’s current revenue?
The current revenue for Akadeum Life Sciences is
. -
How much funding has Akadeum Life Sciences raised over time?
Akadeum Life Sciences has raised $55.4M.
-
Who are Akadeum Life Sciences’s investors?
NYBC Ventures, Innovation Partnerships, Michigan Biomedical Venture Fund, Arboretum Ventures, and ArgoPond are 5 of 35 investors who have invested in Akadeum Life Sciences.
-
Who are Akadeum Life Sciences’s competitors?
LevitasBio, Cytena, FiberCell Systems, Macopharma, and StemCell Technologies are some of the 21 competitors of Akadeum Life Sciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »